We are live on ! Find out more
BNTX icon

BioNTech
BNTX

282 hedge funds and large institutions have $4.34B invested in BioNTech in 2023 Q4 according to their latest regulatory filings, with 70 funds opening new positions, 91 increasing their positions, 70 reducing their positions, and 38 closing their positions.

New
Increased
Maintained
Reduced
Closed

84% more first-time investments, than exits

New positions opened: 70 | Existing positions closed: 38

30% more repeat investments, than reductions

Existing positions increased: 91 | Existing positions reduced: 70

12% more funds holding

Funds holding: 252 → 282 (+30)

8% more capital invested

Capital invested by funds: $4.01B → $4.34B (+$330M)

1.92% more ownership

Funds ownership: 15.42% → 17.33% (+1.9%)

5% more call options, than puts

Call options by funds: $234M | Put options by funds: $224M

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

Holders
282
Holders Change
+30
Holders Change %
+11.9%
% of All Funds
4.11%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
70
Increased
91
Reduced
70
Closed
38
Calls
$234M
Puts
$224M
Net Calls
+$10.8M
Net Calls Change
+$12.2M

Top Buyers

Rank Fund Capital Flow
1
HL
Harding Loevner
New Jersey
+$397M
2
Morgan Stanley
Morgan Stanley
New York
+$68.1M
3
Squarepoint
Squarepoint
New York
+$29.3M
4
Amundi
Amundi
France
+$22.4M
5
UBS AM
UBS AM
Illinois
+$13.8M

Top Sellers

Rank Fund Capital Flow
1
Artisan Partners
Artisan Partners
Wisconsin
-$67.6M
2
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$37.9M
3
Millennium Management
Millennium Management
New York
-$33.5M
4
DTC
Deep Track Capital
Connecticut
-$21.7M
5
CGI
Comgest Global Investors
France
-$20.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
Tudor Investment Corp
301
Tudor Investment Corp
Connecticut
– -$319K -2,934 Closed
AC
302
AXQ Capital
New Jersey
– -$304K -2,800 Closed
JGC
303
J. Goldman & Co
New York
– -$293K -2,700 Closed
CCIA
304
Campbell & Co Investment Adviser
Maryland
– -$290K -2,673 Closed
IFG
305
Independent Financial Group
California
– -$234K -2,156 Closed
VT
306
Vise Technologies
New York
– -$220K -2,022 Closed
SC
307
Saturna Capital
Washington
– -$219K -2,020 Closed
NFC
308
Northeast Financial Consultants
Connecticut
– -$216K -1,989 Closed
SW
309
SVB Wealth
Massachusetts
– -$208K -1,917 Closed
CSPIA
310
Cary Street Partners Investment Advisory
Virginia
– -$186K -1,711 Closed
SOW
311
State of Wyoming
Wyoming
– -$73.7K -678 Closed
BWP
312
Baldwin Wealth Partners
Massachusetts
– -$70.7K -651 Closed
CH
313
Canton Hathaway
Rhode Island
– -$40K -370 Closed
IUHSA
314
Itau Unibanco Holding S.A.
Brazil
– -$30K -276 Closed
CB
315
Community Bank
New York
– -$21.7K -200 Closed
BWL
316
Bogart Wealth LLC
Virginia
– -$10.9K -100 Closed
AF
317
Arrow Financial
New York
– -$5.43K -50 Closed
VNA
318
Valley National Advisers
Pennsylvania
– -$2K -16 Closed
FFA
319
Farther Finance Advisors
California
– -$1.09K -10 Closed
9 10 11 12
13

BNTX Hedge Fund Activity: Q4 2023 in Review

282 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in BioNTech (BNTX) for Q4 2023, worth a combined $4.34B — up 8.2% from $4.01B a quarter earlier.

Buyers outnumbered sellers: 70 funds opened new BNTX positions and 38 closed out — a net gain of 32 holders — while 91 added to existing stakes and 70 trimmed.

The largest buyer was Harding Loevner, opening a new position worth an estimated $397M. The largest seller was Artisan Partners, cutting an estimated $67.6M.

  • 282 institutional investors held BioNTech (BNTX) as of Q4 2023, up from 252 in Q3 2023.
  • Funds reported $4.34B of BioNTech stock for Q4 2023, up 8.2% quarter-over-quarter.
  • 70 funds opened new BioNTech positions in Q4 2023 and 38 closed out, a net change of +32 holders.
  • The largest BioNTech buyer in Q4 2023 was Harding Loevner, an estimated $397M added.
  • The largest BioNTech seller in Q4 2023 was Artisan Partners, an estimated $67.6M sold.

Based on aggregated 13F filings for Q4 2023.